Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts.

Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts.
Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):578-579
Authors: Milione S, Di Caterino M, Monaco L, Rinaldi L
PMID: 29461583 [PubMed - in process]

Source: European Review for Medical and Pharmacological Sciences - February 22, 2018 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research